Navegar

Colección

Datos Estadísticas

Lista de

molecularly targeted therapy
9
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"New insights in cushing disease treatment with focus on a derivative of vitamin A" (2018) Fuertes, M.;Tkatch, J.;Rosmino, J. (...)Arzt, E. Frontiers in Endocrinology. 9(MAY)
"Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys" (2018) Abiuso, A.M.B.;Varela, M.L.;Haro Durand, L. (...)Mondillo, C. European Journal of Cancer. 91:125-135
"Galectin-1: A jack-of-all-trades in the resolution of acute and chronic inflammation" (2017) Sundblad, V.; Morosi, L.G.; Geffner, J.R.; Rabinovich, G.A. Journal of Immunology. 199(11):3721-3730
"Approaches for Designing new Potent Inhibitors of Farnesyl Pyrophosphate Synthase" (2016) Rodriguez, J.B.; Falcone, B.N.; Szajnman, S.H. Expert Opinion on Drug Discovery. 11(3):307-320
"A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis" (2016) Defelipe, L.A.;Do Porto, D.F.;Pereira Ramos, P.I. (...)Marti, M.A. Tuberculosis. 97:181-192
"Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet" (2016) Hockl, P.F.;Wolosiuk, A.;Pérez-Sáez, J.M. (...)Rabinovich, G.A. Pharmacological Research. 109:45-54